Literature DB >> 23466942

Target organ damage and masked hypertension in the general population: the Finn-Home study.

Marjo-Riitta A Hänninen1, Teemu J Niiranen, Pauli J Puukka, Yrjö Antero Kesäniemi, Mika Kähönen, Antti M Jula.   

Abstract

BACKGROUND: The relation of masked hypertension to target organ damage has very seldom been investigated in a general population.
METHODS: An unselected population cohort (n = 1989 of which 1540 were not treated for hypertension) underwent office (duplicate measurements on one visit by a nurse) and home (duplicate measurements on 7 days) blood pressure (BP) measurements and evaluation of electrocardiographic left ventricular hypertrophy (ECG-LVH, n = 1989/1540), carotid intima-media thickness (cIMT, n = 758/592), and pulse wave velocity (PWV, n = 237/158). ECG-LVH was diagnosed using Cornell voltage criteria. PWV was measured using whole-body impedance cardiography. Masked hypertension was defined as office BP less than 140/90 mmHg with home BP at least 135/85 mmHg and white-coat hypertension as office BP at least 140/90 mmHg and home BP less than 135/85 mmHg.
RESULTS: Masked and sustained hypertensive individuals had significantly higher age-adjusted and sex-adjusted Cornell voltage, cIMT, and PWV than normotensive individuals. White-coat hypertensive patients had higher age-adjusted and sex-adjusted Cornell voltage than normotensive individuals but significantly lower Cornell voltage and PWV than sustained hypertensive patients. The differences in Cornell voltage and PWV remained significant after adjustment for confounding factors. However, all differences became nonsignificant after adjustment for systolic home BP.
CONCLUSION: Masked and sustained hypertension is accompanied by increased risk for hypertensive target organ damage, whereas white-coat hypertension seems to be a more benign phenomenon.

Entities:  

Mesh:

Year:  2013        PMID: 23466942     DOI: 10.1097/HJH.0b013e32835fa5dc

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  26 in total

1.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

2.  Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.

Authors:  Teresa Gijón-Conde; Auxiliadora Graciani; Esther López-García; Pilar Guallar-Castillón; Esther García-Esquinas; Fernando Rodríguez-Artalejo; José R Banegas
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

Review 3.  Closer look at white-coat hypertension.

Authors:  Nurver Turfaner Sipahioglu; Fikret Sipahioglu
Journal:  World J Methodol       Date:  2014-09-26

4.  Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.

Authors:  Takeshi Fujiwara; Yuichiro Yano; Satoshi Hoshide; Hiroshi Kanegae; Kazuomi Kario
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

5.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

6.  Masked uncontrolled hypertension in patients on maintenance hemodialysis.

Authors:  Wenjin Liu; Liang Wang; Zhuxing Sun; Xiurong Li; Jianmei Zhou; Chaoqing Gao; Hong Chu; Wei Fan; Youwei Bai; Junwei Yang
Journal:  Hypertens Res       Date:  2017-04-06       Impact factor: 3.872

Review 7.  The complexity of masked hypertension: diagnostic and management challenges.

Authors:  Stanley S Franklin; Nathan D Wong
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 8.  An Update on Masked Hypertension.

Authors:  D Edmund Anstey; Daniel Pugliese; Marwah Abdalla; Natalie A Bello; Raymond Givens; Daichi Shimbo
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

9.  Masked hypertension and kidney function decline: the Jackson Heart Study.

Authors:  Stanford Mwasongwe; Yuan-I Min; John N Booth; Ronit Katz; Mario Sims; Adolfo Correa; Bessie Young; Paul Muntner
Journal:  J Hypertens       Date:  2018-07       Impact factor: 4.844

10.  Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.

Authors:  Stanford E Mwasongwe; Rikki M Tanner; Bharat Poudel; Daniel N Pugliese; Bessie A Young; Marwah Abdalla; Solomon K Musani; Orlando M Gutiérrez; Adolfo Correa; Daichi Shimbo; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-26       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.